The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp191
THE EMERGING ROLE OF MULTI-OMICS IN PERSONALIZING IBD THERAPY
Date
May 18, 2024
Explore related products in the following collection:
Genome-wide association studies revealed single nucleotide polymorphisms (SNPs) associated with inflammatory bowel disease (IBD) in coding regions of autophagy-related genes, such as _ATG16L1_ and _NOD2_…
Vedolizumab (VDZ) is a monoclonal antibody that targets the gut-homing receptor α4β7. Despite its widespread use as a frontline therapy for ulcerative colitis (UC) and Crohn’s disease, its mode of action (MOA) remains unclear…
BACKGROUND: Neutrophil extracellular traps (NETs) consist of DNA filaments and cytoplasmic protein granules, extruded by neutrophils after PAD4-dependent activation…
Background: Although the precise role of eosinophils in IBD is debated, elevated eosinophils may influence response to therapy and clinical outcomes1. Thus, therapeutic agents which affect both neutrophil and eosinophil recruitment may provide more robust clinical improvement in patients with UC…